Stagg; Robert Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stagg; Robert Joseph.The latest application filed is for "methods and compositions for treatment of cancer".

Company Profile

2.8.14

Stagg; Robert Joseph - Moraga CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for treatment of cancer Grant 11,339,213 - Dupont , et al. May 24, 2	2022-05-24
Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent Grant 10,870,693 - Stagg , et al. December 22, 2	2020-12-22
Methods And Compositions For Treatment Of Cancer App 20190023776 - DUPONT; Jakob ; et al.	2019-01-24
Therapeutic Combination And Methods Of Treatment Wtih A Dll4 Antagonist And An Anti-hypertensive Agent App 20180346556 - STAGG; Robert Joseph ; et al.	2018-12-06
Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent Grant 9,982,042 - Stagg , et al. May 29, 2	2018-05-29
Methods and Monitoring of Treatment With A DLL4 Antagonist App 20170299598 - BENNER; Steven Eugene ; et al.	2017-10-19
Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent App 20170166632 - STAGG; Robert Joseph ; et al.	2017-06-15
Methods and monitoring of treatment with a DLL4 antagonist Grant 9,599,620 - Benner , et al. March 21, 2	2017-03-21
Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent Grant 9,511,139 - Stagg , et al. December 6, 2	2016-12-06
Methods And Monitoring Of Treatment With A Dll4 Antagonist App 20160334423 - BENNER; Steven Eugene ; et al.	2016-11-17
Methods for Treating Cancer with DLL4 Antagonists App 20160324961 - STAGG; Robert Joseph ; et al.	2016-11-10
Methods Of Treating Neuroendocrine Tumors Using Frizzled-binding Agents App 20160235844 - Stagg; Robert Joseph ; et al.	2016-08-18
Methods of treating neuroendocrine tumors using frizzled-binding agents Grant 9,266,959 - Stagg , et al. February 23, 2	2016-02-23
Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent App 20150118232 - Stagg; Robert Joseph ; et al.	2015-04-30
Methods of treatment with DLL4 antagonists and an anti-hypertensive agent Grant 8,883,145 - Stagg , et al. November 11, 2	2014-11-11
Methods and Monitoring of Treatment with a DLL4 Antagonist App 20140227252 - BENNER; STEVEN EUGENE ; et al.	2014-08-14
Methods and Monitoring of Treatment with a DLL4 Antagonist App 20140220001 - BENNER; Steven Eugene ; et al.	2014-08-07
Methods Of Treating Neuroendocrine Tumors Using Frizzled-binding Agents App 20140134159 - STAGG; ROBERT JOSEPH ; et al.	2014-05-15
Methods For Treating Cancer With Dll4 Antagonists App 20130323265 - Stagg; Robert Joseph ; et al.	2013-12-05
Therapeutic Combination and Methods of Treatment With a DLL4 Antagonist and an Anti-Hypertensive Agent App 20120263721 - Stagg; Robert Joseph ; et al.	2012-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.